193
Zou X＃, Chang K, Wang Y, Li M, Zhang W, Wang C, Lu B, Xiong Z, Han J, Zhang Y, Zhao J, Cao B＊; for CAP-China Network. Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A andinfluenza B in a prospective cohort from China. Int J Infect Dis. 2019 Jan 8.pii: S1201-9712(19)30005-0. doi: 10.1016/j.ijid.2018.12.014. [Epub ahead of print]
194
Wang J#, Cao B*. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance. Curr Opin Pulm Med. 2018 Dec 12. doi: 10.1097/MCP.0000000000000555.
195
Jia X#, Liu B#, Bao L#, Lv Q, Li F, Li H, An Y, Zhang X*, Cao B*, Wang C*. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018 Nov 13;14(11):e1007428. doi:10.1371/journal.ppat.1007428. eCollection 2018 Nov.
196
Yu D#, Zhang G, Gao L, Xu W, Cao B*. High ratio of measles-specific IgG/IgM associated with nodular pneumonia in vaccinated individuals. Int J Infect Dis. 2018 Nov;76:38-44. doi: 10.1016/j.ijid.2018.08.015. Epub 2018 Aug 28.
197
Zou X#, Guo Q#, Zhang W#, Chen H, Bai W, Lu B, Zhang W, Fan Y, Liu C, Wang Y, Zhou F, Cao B*. Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection. J Infect Dis. 2018; 218(4): 586-594. doi:10.1093/infdis/jiy217.
198
Wang Y#, Guo Q#, Yan Z#, Zhou D#, Zhang W#, Zhou S#, Li Y-P#, Yuan J#, Uyeki TM#, Shen X#, Wu W#, Zhao H, Wu Y-F, Shang J, He Z, Yang Y, Zhao H, Hong Y, Zhang Z, Wu M, Wei T, Deng X, Deng Y, Cai L, Lu W, Shu H, Zhang L, Luo H, ing Zhou Y, Weng H, Song K, Yao L, Jiang M, Zhao B, Chi R, Guo B, Fu L, Yu L, Min H, Chen P, Chen S, Hong L, Mao W, Huang X, Gu L, Li H, Wang C, Cao B*. Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection. J Infect Dis. 2018; 217(11): 1708-1717. doi:10.1093/infdis/jiy115.
199
Han X#, Zhou F, Li H, Xing X, Chen L, Wang Y, Zhang C, Liu X, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Purdy JE, Cao B*. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia. BMC Infect Dis. 2018; 18(1): 192. doi:10.1186/s12879-018-3098-5.
200
Cao B#*, Huang Y#, She D-Y, Cheng Q-J, Fan H, Tian X-L, Xu J-F, Zhang J, Chen Y, Shen N, Wang H, Jiang M, Zhang X-Y, Shi Y, He B, He L-X, Liu Y-N, Qu J-M*. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018; 12(4): 1320-1360. doi:10.1111/crj.12674.
201
Liu M#, Li H, Xue CX, Gu L, Qu JX, Yu XM, Wang YM, Liu YM, Cao B*. Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens. Clin Respir J. 2018; 12(3): 974-985. doi:10.1111/crj.12614.
202
Zhou F#, Gu L, Qu JX, Liu YM, Cao B*. Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China. Clin Respir J. 2018; 12(2): 425-432. doi:10.1111/crj.12533.
203
Chen L#, Zhou F, Li H, Xing X, Han X, Wang Y, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Uyeki TM, Wang C, Cao B*. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open. 2018; 8(2): e018709. doi:10.1136/bmjopen-2017-018709.
204
Zhang Y#, Wang Q#, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, Li W, Zhang X, Liao K, Man S, Wang S, Wen H, Li B, Guo Z, Tian J, Pei F, Liu L, Zhang L, Zou C, Hu T, Cai J, Yang H, Huang J, Jia X, Huang W, Cao B*, Wang H*. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018, 25; 62(2). pii: e01882-17. doi:10.1128/AAC.01882-17.Print 2018 Feb.
205
Zhou F#, Li H, Gu L, Liu M, Xue C, Cao B*, Wang C. Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients. Respir Med. 2018; 134: 86-91. doi:10.1016/j.rmed.2017.11.017.
206
Huang L#, Zhang W#, Yang Y#, Wu W#, Lu W#, Xue H, Zhao H, Wu Y, Shang J, Cai L, Liu L, Liu D, Wang Y, Cao B*, Zhan Q*, Wang C. Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis. 2018; 18(1): 23. doi:10.1186/s12879-017-2903-x.
207
Li H#, Bradley KC#, Long JS, Frise R, Ashcroft JW, Hartgroves LC, Shelton H, Makris S, Johansson C, Cao B*, Barclay WS*. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. Plos Pathogens. 2018; 14(1): e1006821. doi: 10.1371/journal.ppat.1006821.
208
Yin YD#, Wang R, Zhuo C, Wang H, Wang MG, Xie CM, She DY, Yuan X, Wang RT, Cao B*, Liu YN*. Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study. J Thorac Dis. 2017; 9(10): 3774-3781. doi:10.21037/jtd.2017.09.75.
